EAG expands biopharma analysis capabilities in 'major investment'
EAG has further invested in ABC Laboratories' capacity and analytical capabilities in order to help meet demand for high-end biopharmaceutical analysis.
Archives for May 19, 2016
Mundipharma releases 2-year Remsima efficacy data
Mundipharma has begun the latest phase of its Remsima promotion campaign, unveiling two-year data indicating the infliximab biosimilar is as safe and effective as the originator.